Jonas Schoendube
Directeur/Bestuurslid bij Cytena Bioprocess Solutions
Oorsprong van het eerstegraads netwerk van Jonas Schoendube
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
cytena GmbH
 cytena GmbH BiotechnologyHealth Technology cytena GmbH develops a device for separating of single cells. It has developed a device called cy-Clone to separate single cells and these single cells are required for the development of state-of-the-art drugs, so-called biologicals as well as for the genetic analysis of single cells for cancer and stem cell research, the cy-Clone is supported by an automated imaging process to encapsulate cells in droplets, which are delivered to any type of substrate. The company was founded by Peter Koltay, Benjamin Steimle, Jonas Schoendube and Andre Gross in August 2014 and is headquartered in Freiburg, Germany.
3
| Subsidiary | Biotechnology | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Jonas Schoendube via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|
Statistieken
Internationaal
Sectoraal
Operationeel
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
| Director of Finance/CFO | 1 |
| Public Communications Contact | 1 |
Sterkste connecties
| Insiders | |
|---|---|
| Andre Gross | 1 |
| Peter Koltay | 1 |
| Benjamin Steimle | 1 |
- Beurs
- Insiders
- Jonas Schoendube
- Bedrijfsconnecties
